Causeway Sensors
Bioprocess sensor for at-line, real-time IgG quantification in bioreactor samples, for biopharma bioproduction teams
Highlights
- New on EvolcAdded 2026-10-30
About Causeway Sensors
Causeway Sensors develops a compact at-line device that measures IgG concentration directly from bioreactor samples in real time, based on a nanotechnology sensor platform developed at Queen's University Belfast.
The company serves bioproduction settings, and its website invites organisations to join a beta programme for the device.
Causeway Sensors Limited was founded in 2013 and is headquartered in Belfast, Northern Ireland. The leadership team includes CEO Antony Murphy and founder and executive chairman Bob Pollard, and the company has raised over £3.3M in venture capital investment according to its team page.
Product: Compact at-line device measuring IgG directly from bioreactor samples in real time.
Jobs at Causeway Sensors
Leadership
- Antony Murphy · Chief Executive OfficerSource: company website
- Deirdre Francis · Finance DirectorSource: company website
More biotech & pharma companies
Cellcentric
Develops an oral cancer drug for people with multiple myeloma and other cancersNew on EvolcCellcraft
AI bioprocess control software and related tools for biomanufacturers and bioprocess teamsCentauri Therapeutics
Develops Alphamer immunotherapies for infectious diseases, including Gram-negative bacterial infections in high-risk patientsNew on EvolcCerevance
Develops cell-type-specific therapies and drug targets for patients with neurodegenerative, psychiatric and CNS disordersNew on EvolcChemify
Automated chemistry systems that help pharmaceutical and materials partners design and synthesize moleculesNew on EvolcCizzle Biotechnology
Non-invasive blood test for early lung cancer detection based on the CIZ1B biomarker, aimed at healthcare providers and patientsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Squarespace